- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 39/02 - Antidotes
Patent holdings for IPC class A61P 39/02
Total number of patents in this class: 421
10-year publication summary
6
|
24
|
16
|
21
|
35
|
31
|
42
|
34
|
45
|
14
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 18943 |
12 |
Kureha Corporation | 1026 |
7 |
Centre National de La Recherche Scientifique | 9632 |
6 |
The Arizona Board of Regents on Behalf of the University of Arizona | 1906 |
6 |
Jiangnan University | 1410 |
6 |
Commissariat à l'énergie atomique et aux energies alternatives | 10525 |
5 |
Universite de Strasbourg | 646 |
5 |
Murata Manufacturing Co., Ltd. | 22355 |
4 |
Daiichi Sankyo Company, Limited | 1829 |
4 |
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | 357 |
4 |
Her Majesty the Queen in Right of Canada, as represented by the Minister of National Defence | 217 |
4 |
Kyowa Hakko Bio Co., Ltd. | 296 |
4 |
Shionogi & Co., Ltd. | 914 |
4 |
Naval Medical University | 4 |
4 |
Novartis AG | 11238 |
3 |
Takeda Pharmaceutical Company Limited | 2961 |
3 |
Asahi Group Holdings, Ltd. | 383 |
3 |
Biohit Oyj | 46 |
3 |
Jiangsu Hengrui Medicine Co., Ltd. | 780 |
3 |
Kyushu University, National University Corporation | 1572 |
3 |
Other owners | 328 |